Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - ganirelix, quantity: 0.25 mg - injection, solution - excipient ingredients: glacial acetic acid; water for injections; mannitol; sodium hydroxide - for the prevention of premature luteinisation and ovulation in patients undergoing controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

theramex ireland ltd. - drospirenone 3 mg; ethinylestradiol 0,02 mg - film-coated tablet - 0,02 mg - 3 mg - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and ethinylestradiol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

theramex ireland ltd. - drospirenone 3 mg; ethinylestradiol 0,03 mg - film-coated tablet - 0,03 mg - 3 mg - ethinylestradiol 0.03 mg; drospirenone 3 mg - drospirenone and ethinylestradiol

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - risedronate sodium, quantity: 30 mg (equivalent: risedronic acid, qty 27.84 mg) - tablet, film coated - excipient ingredients: crospovidone; hypromellose; macrogol 400; hyprolose; titanium dioxide; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; macrogol 8000; lactose monohydrate - treatment of paget's disease of bone.

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - risedronate sodium, quantity: 5 mg (equivalent: risedronic acid, qty 4.64 mg) - tablet, film coated - excipient ingredients: iron oxide yellow; microcrystalline cellulose; titanium dioxide; hypromellose; crospovidone; hyprolose; colloidal anhydrous silica; macrogol 8000; macrogol 400; lactose monohydrate; magnesium stearate - treatment of osteoporosis. treatment of glucocorticoid-induced osteoporosis. preservation of bone mineral density in patients on long-term corticosteroid therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - estradiol hemihydrate, quantity: 1 mg; progesterone, quantity: 100 mg - capsule, soft - excipient ingredients: mono- and di- glycerides; gelatin; glycerol; purified water; lauroyl macrogolglycerides; hydrolysed gelatin; allura red ac; titanium dioxide; propylene glycol; ethyl acetate; ethanol; isopropyl alcohol; strong ammonia solution; polyvinyl acetate phthalate; macrogol 400 - bijuva 1/100 is indicated for use during continuous combined hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women with an intact uterus and with at least 12 months since last menses.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

theramex ireland ltd. - calcium carbonate 1250 mg - eq. calcium 500 mg; cholecalciferol concentrate powder form 20 mg - eq. cholecalciferol 2000 iu - chewable tablet - calcium, combinations with vitamin d and/or other drugs

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

theramex ireland ltd. - calcium carbonate 1250 mg - eq. calcium 500 mg; cholecalciferol concentrate powder form 20 mg - eq. cholecalciferol 2000 iu - chewable tablet - calcium, combinations with vitamin d and/or other drugs

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - levonorgestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet, film coated - excipient ingredients: lactose; hypromellose; microcrystalline cellulose; magnesium stearate; polysorbate 80; titanium dioxide; macrogol 400; allura red ac aluminium lake; brilliant blue fcf aluminium lake - seasonique is indicated for use as an oral contraceptive.

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - risedronate sodium -